Holdings

Defilade Capital Management, L.P.

As of Sep 30, 2026, Defilade Capital Management, L.P. reported 28 positions worth US$550M. Largest: Pfizer, Inc., Eli Lilly and Company and BioMarin Pharmaceutical Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Pfizer, Inc.1.52MUS$43.5M−247KSep 30, 2026
Eli Lilly and Company34,774US$40.2M−4,312Sep 30, 2026
BioMarin Pharmaceutical Inc.602KUS$36.1M−80,083Sep 30, 2026
Gilead Sciences, Inc.227KUS$33.8MnewSep 30, 2026
Axsome Therapeutics, Inc.175KUS$32.3MnewSep 30, 2026
Amgen Inc.74,079US$31.2MnewSep 30, 2026
ORIC Pharmaceuticals, Inc.2.27MUS$30.6M+1.22MSep 30, 2026
Intuitive Surgical, Inc.71,860US$29.2MnewSep 30, 2026
Stryker Corporation81,524US$22.5MnewSep 30, 2026
Vera Therapeutics, Inc.652KUS$21.1MnewSep 30, 2026